None of the information provided is investment or tax advice.
You should always read the associated risks before deciding whether to invest. These can be found on the product pages as well as in our risks overview.
Please confirm you have read the information above.

Confirm

Welcome to Downing LLP

Other
plus icon
document search icon 3
11/11/2020
5
min read

British man born without hand gets real life ‘Metal Gear Solid’ Bionic arm

No items found.
Downing
Downing

Downing launches new actively managed liquid alternatives fund aiming to deliver 7% to 10%+ per annum and positive returns in most markets. The new MGTS Downing Active Defined Return Assets Fund (‘Active Defined Returns’, the ‘Fund’), is the first fund from its new Liquid Alternatives team.

The Fund is aimed at institutional investors, Discretionary Fund Managers, IFAs and advised sophisticated individual investors, and will primarily consist of UK Government bonds and large-cap equity index options, which provide significant scalability and strong liquidity. It aims to deliver 7% to 10%+ per annum and positive returns in all markets except for a sustained equity market fall (generally more than 35%), over a period of at least six years.  

The Fund is the first to be launched by the new Liquid Alternatives Team established by Downing. Collectively, the team has over 125 years of experience and sector knowledge, and includes Tony Stenning, who held senior roles at BlackRock and most recently was CEO of Atlantic House Group; Russell Catley, founder and also a former CEO of Atlantic House Group; Huw Price, a former Executive Director at Santander Asset Management, and Paul Adams, former Head of Cash Equities and Derivatives Sales, Royal Bank of Canada.          

The Fund offers investors a compelling building block for multi-asset portfolios, aiming to add consistent and predictable returns, typically secured with a portfolio of UK Government bonds. The unique proposition includes a hybrid approach of using systematic derivative strategies and active management, combining liquid investments with predictable returns, and an equity like risk profile.

Investment strategy: Maximising the probability of delivering predictable defined returns across the economic cycle.

  • Systematic Liquid Derivatives:  Systematic, derivative strategies optimise the equity risk-return profile. The Fund uses rules-based derivative strategies linked to the most liquid, large-cap global equity indices (i.e. FTSE100, S&P500) with the aim of harvesting well-proven consistent returns across a wide corridor of market conditions. 
  • Strong security:  The Fund will hold a high-quality portfolio of assets as secure collateral – typically UK Government bonds.
  • Active benefits: At times, rules-based, passive derivative strategies can underperform when markets move strongly – this is when specialist active management can add incremental gains by monitoring and monetising positions and applying active risk management.

Key benefits

  • Increased consistency and predictability of returns: Positive returns in all markets except for a sustained equity market fall of more than 35% over at least six years.
  • Diversification of risk: The Fund’s risk components are diversified across large, liquid equity indices, observation levels and counterparties. Secured with high-quality assets – typically UK Government bonds.
  • Active management: Our experienced team will actively manage the Fund and its investments to optimise risk and reward for investors.
Russell Catley, Head of Retail, Liquid Alternatives at Downing, said: “Put simply, we focus your investment risk on the probability of receiving the returns you need, not those you don’t.  We target the highest probability of delivering 7% to 10%+ per annum with active management adding material incremental gains. We believe that we are building the next evolution of the proven success of Defined Returns funds
The Downing team is seeing strong demand from clients looking for alternatives to large-cap equity funds which are becoming concentrated in technology stocks, or alternatives to UK equity income funds and illiquid alternatives.”   
Tony Stenning, Head of Liquid Alternatives at Downing, said: “The launch of our Active Defined Return Assets Fund is a significant milestone in the ambitious build-out of our new Liquid Alternatives strategies. It is a solution-focused fund that should deliver stable high single or low double-digit returns across a wide spectrum of equity market conditions, except for a persistent multi-year bear market. The Fund is designed to enhance balanced portfolios by providing consistent, predictable returns and is suitable for accumulation or drawdown.
“We aim to deliver a unique combination of proven systematic derivative strategies and specialist active management, and we are doing so at a very compelling fee level, below our closest competitors and in line with active ETFs.”

How the Fund is expected to perform in different markets

  • In bullish markets:  UK Government bonds secure the capital, and the equity index options deliver a predictable 7-10%+ return per annum – giving up some less likely upside.
  • In neutral markets and normal market corrections:  UK Government bonds secure the capital, and the index options deliver a predictable 7-10%+ return per annum.
  • In a sustained sell-off:  if markets fall more than the cover to capital loss and do not recover for six years. Then capital is eroded 1:1 in line with the worst performing index.
  • The average Cover to Capital Loss is targeted at 35%:  the average cover to capital loss represents the average level the Global indices within the Fund could fall before capital is at risk.

Fund key risks

  • Performance:  Capital is at risk. Investors may not get back the full amount invested.
  • Liquidity:  Access to capital is always subject to liquidity.
  • Counterparty risk: Other parties could default on the contractual obligations.

Fund Structure

  • UK regulated OEIC fund structure, fully UCITS compliant
  • Daily dealing, at published NAV
  • Minimum investment: £100,000
  • SRRI: 6 out of 7
  • Depositary: Bank of New York
  • Authorised corporate Director (‘ACD’): Margetts Fund Management Ltd.
  • I share-class:  SEDOL: BM8J604 / ISIN: GB00BM8J6044
  • F share-class: SEDOL: BM8J615 / ISIN: GB00BM8J6150

Learn more about the Fund here.


Risk warning: Opinions expressed represent the views of the fund manager at the time of publication, are subject to change, and should not be interpreted as investment advice. Please refer to the latest full Prospectus and KIID before investing; your attention is drawn to the risk, fees and taxation factors contained therein. Please note that past performance is not a reliable indicator of future results. Capital is at risk. Investments and the income derived from them can fall as well as rise and investors may not get back the full amount invested. Investments in this fund should be held for the long term. 

Important notice: This document is intended for professional investors and has been approved as a financial promotion in line with Section 21 of the FSMA by Downing LLP (“Downing”). This document is for information only and does not form part of a direct offer or invitation to purchase, subscribe for or dispose of securities and no reliance should be placed on it. Downing does not offer investment or tax advice or make recommendations regarding investments. Downing is a trading name of Downing LLP. Downing LLP is authorised and regulated by the Financial Conduct Authority (Firm Reference No. 545025). Registered in England and Wales (No. OC341575). Registered Office: 10 Lower Thames Street, London EC3R 6AF.

Gaming giant KONAMI DIGITAL ENTERTAINMENT Inc. have teamed up with award-winning prosthetics company Open Bionics to release an official Metal Gear Solid “Venom Snake” bionic arm for below-elbow amputees. The striking new design clips onto Open Bionics’ ‘Hero Arm’, which is the world’s most affordable multi-grip bionic arm.

29-year-old Daniel Melville, who was born without his right hand and has been wearing a Hero Arm for over 3 years, is the very first recipient of the new Metal Gear Solid design. Daniel, from Reading, U.K., said: “This is unbelievable. It’s everything I’ve ever wanted from a bionic arm. I’m an avid gamer and love Metal Gear Solid so much and to actually have Snake’s arm in real life is just insane.”

Venom Snake, a mercenary leader voiced by Kiefer Sutherland, is the protagonist of Metal Gear Solid V: The Phantom Pain, which was released in 2015 to critical acclaim. The fictional character lost his arm in an explosion and wears an iconic red and black bionic arm complete with detachable missile functionality and gadgets to stun enemies. 

Whilst the Hero Arm isn’t equipped with weapons, it is an impressive feat of engineering that is changing the lives of hundreds of upper limb amputees; both adults and children as young as eight years old. Bristol-based Open Bionics use 3D printing and 3D scanning, along with some clever software and design to custom-manufacture each Hero Arm, which can then be accessorised with magnetic clip-on covers. The Metal Gear Solid “Venom Snake” covers are available now.

Takayuki Kubo, President of KONAMI DIGITAL ENTERTAINMENT, Inc., said: “We’re incredibly excited to collaborate with Open Bionics, who are at the cutting edge of robotics. We’re thrilled to see the iconic Metal Gear aesthetic of Venom Snake and his bionic arm burst out of the screen and come to life, in a dynamic fusion of technology and design that is changing the lives of upper limb amputees all over the world.”

Samantha Payne, COO and Co-founder of Open Bionics, said: “Since Open Bionics founded six years ago, Snake’s arm is one of the most requested cover designs for the Hero Arm, so we’re delighted to offer this to our users and grateful to KONAMI for collaborating to make fiction a reality. This collaboration came about from a mutual appreciation of art, science, and technology. It’s pure joy to see this piece of engineering and art impact a person’s life. Upper limb amputees can sign-up for a Hero Arm on our website.”

Upper limb amputees interested in getting a Hero Arm can register interest at www.openbionics.com/sign-up where Open Bionics will determine eligibility and arrange an assessment. The Metal Gear Solid “Venom Snake” Covers are available for Hero Arm users to buy now online for delivery by Christmas:  www.openbionics.com/metal-gear-solid-snake-arm

Open Bionics is one of Downing Ventures portfolio companies. Open Bionics was found in 2014 by Joel Gibbard MBE and Samantha Payne MBE with the goal of developing affordable, assistive devices that enhance the human body. In other words, Open Bionics turns disabilities into superpowers. The Bristol-based bionics company is known globally for using 3D printing and 3D scanning to make advanced, affordable and accessible bionic limbs. In October 2020, Open Bionics launched the latest version of its Hero Arm, bringing greater reliability, comfort and quality to their flagship product, with upgrades that include robust laser-sintered frames, innovative socket technology, and new magnetic covers. Children and adults with below-elbow limb differences can register interest at: www.openbionics.com/sign-up

Share
https://downing.co.uk/insights/british-man-born-without-hand-gets-real-life-metal-gear-solid-bionic-arm

We're here to help

If you are a financial adviser, or discretionary fund manager call 020 7630 3319 or email us at sales@downing.co.uk

If you are a private investor call  020 7416 7780 or email customer@downing.co.uk